These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31460497)

  • 1. Medication Therapy Management Delivery by Community Pharmacists: Insights from a National Sample of Medicare Part D Beneficiaries.
    Adeoye OA; Farley JF; Coe AB; Pestka DL; Farris KB; Zillich AJ; Snyder ME
    J Am Coll Clin Pharm; 2019 Aug; 2(4):373-382. PubMed ID: 31460497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.
    Pestka DL; Zillich AJ; Coe AB; Farris KB; Adeoye OA; Snyder ME; Farley JF
    J Am Pharm Assoc (2003); 2020; 60(3):456-461. PubMed ID: 31926872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare medication therapy Management: Beneficiary characteristics and utilization patterns in a national CMS Medicare fee-for-service sample (2013 to 2016).
    Oyarzún-González X; Abner EL; Freeman P; Kucharska-Newton A; Fardo DW; Moga DC
    J Am Pharm Assoc (2003); 2024; 64(5):102140. PubMed ID: 38825153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining Medicare Part D Medication Therapy Management program in the context of mental health.
    Murugappan MN; Seifert RD; Farley JF
    J Am Pharm Assoc (2003); 2020; 60(4):571-579.e1. PubMed ID: 31953120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program.
    Allen A; Hung A
    J Manag Care Spec Pharm; 2024 Jun; 30(6):609-616. PubMed ID: 38824629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprint of: Examining Medicare Part D Medication Therapy Management program in the context of mental health.
    Murugappan MN; Seifert RD; Farley JF
    J Am Pharm Assoc (2003); 2020; 60(5S):S54-S63. PubMed ID: 32977930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Medication Changes Resulting from Comprehensive and Noncomprehensive Medication Reviews in a Medicare Part D Population.
    Buhl A; Augustine J; Taylor AM; Martin R; Warholak TL
    J Manag Care Spec Pharm; 2017 Mar; 23(3):388-394. PubMed ID: 28230451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
    O'Shea TE; Zarowitz BJ; Erwin WG
    J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.
    Coe AB; Adeoye-Olatunde OA; Pestka DL; Snyder ME; Zillich AJ; Farris KB; Farley JF
    Res Social Adm Pharm; 2020 Sep; 16(9):1208-1214. PubMed ID: 31859225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
    Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
    Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
    Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
    J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
    Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
    J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and ethnic disparities in Medicare Part D medication therapy management services utilization.
    Dong X; Tsang CCS; Browning JA; Garuccio J; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J; Wang J
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100222. PubMed ID: 36712831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Socioeconomic and Geographical Characteristics of Beneficiaries Receiving a Comprehensive Medication Review.
    Chou J; Pellegrin K; Cooke CE; Zarowitz B; Hanlon A; Lozano A; Brandt NJ
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1276-1281. PubMed ID: 32996388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and implementation of a telephone medication therapy management program for Medicare beneficiaries.
    Moczygemba LR; Barner JC; Gabrillo ER; Godley PJ
    Am J Health Syst Pharm; 2008 Sep; 65(17):1655-60. PubMed ID: 18714113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient satisfaction with a pharmacist-provided telephone medication therapy management program.
    Moczygemba LR; Barner JC; Brown CM; Lawson KA; Gabrillo ER; Godley P; Johnsrud M
    Res Social Adm Pharm; 2010 Jun; 6(2):143-54. PubMed ID: 20511113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive deviants for medication therapy management: A mixed-methods comparative case study of community pharmacy practices.
    Adeoye-Olatunde OA; Lake LM; Strohmier CA; Gourley AK; Ray AR; Zillich AJ; Snyder ME
    Res Social Adm Pharm; 2021 Aug; 17(8):1407-1419. PubMed ID: 33214124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with comprehensive medication review completion rates: A national survey of community pharmacists.
    Snyder ME; Jaynes HA; Gernant SA; Lantaff WM; Doucette WR; Hudmon KS; Perkins SM
    Res Social Adm Pharm; 2020 May; 16(5):673-680. PubMed ID: 31439525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.